Apollomics APLM
NASDAQ APLM
$22.05 +0.95 (+4.56%)
As of: Oct 19, 2026 · 12:55 PM EDT

Apollomics (APLM) Total Debt (2023 - 2024)

Updated

Apollomics' Total Debt was $3.51 million in Q2 2024.

Analysis

Apollomics (APLM) Total Debt (2023 - 2024) Analysis & Trends

At the end of FY2023, Total Debt at Apollomics came in at $4.24 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 49.04 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 70.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 63.19 Bn
10 Apollomics 44.32 Mn 3.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3.51 Mn
Dec 31, 2023 4.24 Mn
API Access

Apollomics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=APLM&period=max&api_key=YOUR_API_KEY